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Summary
Both atherosclerosis and osteoporosis are responsible for
significant morbidity and mortality, are independent predic-
tors of cardiovascular disease (CVD) events, and may share
common regulatory mechanisms as well as histopathology.
Abdominal aortic calcification (AAC), an indication of athero-
sclerosis, is significantly associated with both cardiovascular
heart disease and stroke. The increased risk of cardiovascular
disease mortality associated with moderate to severe AAC is
similar to the increased risk of hip fracture in the presence of
a moderate to severe vertebral fracture. A negative associa-
tion between bone mineral density (BMD) and AAC severity
has been also demonstrated. 
Several non-invasive methods are available to investigate the
presence and the severity of osteoporosis. With some of
these is possible to measure aortic calcification and bone
mass in the same exam. A new method for the evaluation of
aorta calcification by dual X-Ray absorptiometry (DXA) has
been recently suggested: the Instant Vertebral Assessment
(IVA), which offers the possibility to obtain in the same scan
an assessment of vertebral fracture and AAC. Therefore, a sin-
gle IVA exam could assist in stratifying patients into high and
low risk groups for two highly prevalent and significant health
care problems.
KEY WORDS: aortic calcification, bone mineral density, dual X-ray absorp-
tiometry, quantitative computed tomography, instant vertebral assessment.
Introduction
Cardiovascular events and osteoporotic fractures are major
causes of morbidity and mortality in elderly (1-4). 
Cardiovascular disease (CVD) often presents atypically, mak-
ing clinical recognition difficult; the need for timely referral of
high-risk individuals identified by different independent predic-
tors of cardiovascular risk is also urged by the fact that more
than two-third of women suddenly die for cardiovascular events
without prior sign of the disease (5). Prevalence of these
events is expected to rise in upcoming years owing the in-
creasing longevity of population in most of the industrialized
countries of the world. Important studies, based on prospective
cohort of the Framingham Heart Study and the Rotterdam
Study, have demonstrated that men and women with calcific
diseases in the abdominal aorta are more likely to develop
coronary heart disease (CHD), CVD, and CVD mortality (6)
and that aortic calcifications are stronger predictors of incident
stroke (7). In a recent paper carried out in 1453 women and
1046 men (mean age 61 years) followed for 35 years, a strong
association between aortic calcification and increased of death
has been confirmed (8): in fact mortality was 91% in women
and 94% in men with aortic calcification compared to 60% in
women and 74% in men without aortic calcification, with a lin-
ear increase of hazard ratios for mortality according to the
severity of aortic calcification score (8). The increased risk of
CVD mortality associated with abdominal aortic calcification
(AAC) is similar to the increased risk of hip fracture in the pres-
ence of a moderate to severe vertebral fracture. 
Several studies have also showed that low bone mass and os-
teoporotic fractures are independent predictors of mortality in
men and women (2, 3, 9, 10). 
A positive association between osteoporosis and CVD has
been reported in prospective study and in retrospective analy-
sis (11, 12). Tanko et al., in more than 2500 women assigned
to placebo and followed for 4 years in an osteoporosis treat-
ment trial, showed that postmenopausal osteoporotic women
are at an increased risk for cardiovascular events that is pro-
portional to the severity of osteoporosis at the time of the diag-
nosis: the incidence of cardiovascular events was 3.8% in os-
teoporotic women, and 0.9% in women with low bone mass
with an 3.9-fold increase of risk for acute cardiovascular events
in women with osteoporosis (11). In the same study it has been
showed that incidence of cardiovascular events is associated
with the number and the severity of vertebral fractures (11).
Ness et al., in a retrospective analysis of 1000 postmenopausal
women, demonstrated an association between low BMD and
atherosclerotic vascular disease (12). An unified hypothesis of
vascular calcification that combines both active and passive
mechanisms of vascular mineralization with aspects of bone
resorption and age-related changes has been recently pro-
posed (13).
In the last 25 years, several non-invasive techniques have
been developed to quantify bone mineral density in the axial
and peripheral skeleton, some of these also offer the possibility
to assess and quantify vascular calcification. 
Conventional Radiography (Xr)
Vertebral fractures are the most common of all osteoporotic
fractures and are present in a significant percentage (25%) of
the population over the age of 50, especially in Caucasian
women and men in Europe and the United States (14-18). Ver-
tebral fractures are associated to an increased mortality rate
(18) and loss of independence and impaired quality of life (19,
20). Even asymptomatic, vertebral fractures could have clinical
consequences for the patient because of the increased, ap-
proximately five-fold, risk of future fractures that may be symp-
tomatic (21). For these reasons the prevention of future frac-
tures for patients with vertebral fractures has been considered
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the endpoint in clinical trials on osteoporosis therapy (22-26).
Because a majority of vertebral fractures often occur in ab-
sence of specific trauma and are asymptomatic, they are often
difficult to identify clinically. It is in the accurate diagnosis of
asymptomatic vertebral fractures that radiologists make per-
haps the most significant contribution to osteoporotic patient
care. In everyday clinical practice, the qualitative reading of
spinal radiographs is still the standard tool to identify vertebral
fractures. The assessment by radiologists of conventional radi-
ographs of the thoracic and lumbar spine in lateral and anteri-
or-posterior (AP) projections generally is uncomplicated, allow-
ing the identification of moderate and severe vertebral frac-
tures. However, the osteoporotic vertebral fractures often ap-
pears such as mild vertebral deformities, without the visible dis-
continuity of bone architecture. So the visual radiological ap-
proach may cause disagreement about whether a vertebra is
fractured (27). In an effort to improve the accuracy of the diag-
nosis of vertebral fractures was introduced more than a decade
ago the semiquantitative assessment (SQ) and the quantitative
measurement of vertebral heights (e.g., vertebral morphome-
try) for the definition of vertebral fractures.
In this approach the conventional radiographs are evaluated by
skeletal radiologists or experienced clinicians in order to identi-
fy and to classify the vertebral fractures (28). Vertebrae T4-L4
are graded by visual inspection and without direct vertebral
measurement as normal (grade 0), mild fracture (grade 1 with
approximately 20-25% reduction in anterior, middle, and/or
posterior height and 10-20% reduction in area), moderate frac-
ture (grade 2 with approximately 25-40% reduction in any
height and 20-40% reduction in area), and severe fracture
(grade 3 with approximately 40% or greater reduction in any
height and area). Incident fractures are defined as those verte-
brae that show a higher deformity grade on the follow-up radi-
ographs. The SQ method is a simple but standardized ap-
proach that provides reasonable reproducibility, sensitivity, and
specificity, allowing excellent agreement for the diagnosis of
prevalent and incident vertebral fractures to be achieved
among trained observers (29).
From lumbar Xr it is possible to assess the location, severity
and progression of aortic calcification (30). Kauppila et al. de-
veloped a reliable indices of the radiopaque calcifications in the
abdominal aorta, which include assessment of individual aortic
segments and summary scores, derived from the severity
scores of the individual aortic segments. This approach pro-
vides a fast and low-cost assessment of location and severity
of aortic atherosclerosis. The scoring systems are a practical
tool to follow the progress of aortic calcification. Furthermore,
these measure have been applied to several studied that in-
vestigate the correlates and outcomes of aortic calcification (8,
31). Kiel et al. performed lateral lumbar spine and hand radi-
ograph between 1966 and 1970 and repeated between 1992
and 1993, to evaluate aortic calcification, according to the
Kauppila method (30), and bone mass (by radiogrammetry), in
364 women and 190 men from the original population-based
Framingham Heart Study cohort (31). This longitudinal study
showed that women with the greatest magnitude of bone loss
demonstrate the most severe progression of abdominal aortic
calcification, suggested that the two processes may be related
(31). The same quantitative method to grade the severity of
vascular calcification has been utilized in a recent paper that
examines the relation between severity of vascular calcification
in middle-age years and subsequent risk of hip fracture in men
and women in the population-based Framingham Study (8). In
this study, no evidence that vascular calcification increases
subsequent risk hip fracture in men or women was found, sug-
gesting that common radiographic finding of aortic calcification
cannot be recommended in the clinical setting for identifying
persons at increased risk of hip fracture (8). On the contrary,
Naves M. et al. have recently demonstrated an independent
positive and statistically significant association between the
severity of aortic calcifications and osteoporotic fractures, par-
ticularly prevalent vertebral fractures; in this study a positive
association between the progression of aortic calcifications and
the rate of decline in BMD at lumbar spine has been also
showed (32). 
Quantitative ultrasound of bone (QUS)
Quantitative ultrasound (QUS) methods have been introduced
for the assessment of skeletal status in osteoporosis and, be-
cause of the lack of ionising radiation, relative portability of the
equipment, ease of use, and low cost, has seen marked suc-
cess around the world.
Ultrasound is a mechanical wave vibrating at a frequency
range from 20.000 waves/s to 100.000 waves/s; when these
waves pass through bone, the physical and mechanical proper-
ties of the bone alter the shape, the intensity and the speed of
the propagation of the wave. Velocity and attenuation are ultra-
sound variables commonly evaluated. The velocity of ultra-
sound wave propagation is determined by the transit time and
by the width crossed, and it is expressed as m/s. Current com-
mercial systems for studying the bone use two transducers (a
transmitter and a receiver), positioned on each side of the tis-
sue to be measured, or a single transducer that transmits and
receives the signal. Attenuation (broadband ultrasound attenu-
ation, BUA) of the wave is determined by mechanisms of dif-
fraction, scattering and absorption in the bone, marrow and soft
tissue. Absorption predominates in cortical bone and scattering
in trabecular bone. Attenuation is a measure of the frequency
dependence of the attenuation of ultrasound. This dependence
is approximately linear and it is expressed on a logarithmic
scale over the range 0.1-1 MHz. The increase in attenuation as
a function of the frequency is measured by comparing the am-
plitude spectrum for a reference material with that of the mea-
sured sample. The slope of attenuation (BUA) in dB/MHz is
given by linear regression of the spectral amplitude difference.
Combined parameters, derived from the mathematical combi-
nation of SOS and BUA, have been developed by Lunar (Stiff-
ness) and Hologic (Quantitative Ultrasound Index = QUI). The
combination of BUA and SOS into a single parameter has been
shown to improve precision; furthermore, from the point of view
of clinical interpretation, a single parameter, which combines
velocity and attenuation, can simplify interpretation. 
Different manufacturers have developed several ultrasound de-
vices since the late 1980s, and continuing improvements have
been made in recent years. QUS devices can measure velocity
and attenuation at different skeletal sites: calcaneus, phalanx-
es and tibia. Also “multisite” devices can measure US parame-
ters at different skeletal sites such as radius, phalanxes, calca-
neus. The calcaneus, composed almost entirely of trabecular
bone is the most studied and validated skeletal site for QUS
assessment; in fact, the high percentage of trabecular bone,
which has a turnover higher than cortical bone, allows early ev-
idence of metabolic changes. Another good site is the distal
metaphysis of the first phalanx of the last four fingers. At this
level, both cortical and trabecular bone are present; both of
which are sensitive to age-related bone resorption and are ap-
propriate for the evaluation of osteoporotic fracture risk. It is
currently accepted that QUS parameters are not only influ-
enced by bone density, but also by bone structure and compo-
sition (33). Theory suggests that BUA is determined by bone
density and bone microarchitecture, while SOS is influenced by
the elasticity of bone as well as by bone density. However, the
exact mechanisms of ultrasound interaction with bone and the
physical properties measured remain undetermined (33). The
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relative contribution to bone assessment of both ultrasound
and the current gold standard method for bone assessment,
dual x-ray absorptiometry (DXA), is still to be determined; nev-
ertheless, QUS has demonstrated that it is able to detect bone
fragility as well as DXA (34-38). 
QUS at calcaneus [osteo-sono assessment index (OSI)] to as-
sess osteopenia and brachial-ankle pulse wave velocity (baP-
WV) to assess atherosclerosis have been utilized in a Japan-
ese study aimed to evaluate the relationship between athero-
sclerosis and bone mass (39). In this study, a significant nega-
tive correlation between baPWV and OSI has been showed
suggesting that common or related mechanisms control both
atherosclerosis and osteoporosis from the early stages (39). 
Computed tomography 
Quantitative computed tomography (QCT) is a three-dimen-
sional technique that measures BMD volumetrically and that
permits separate characterization of bone geometry and bone
density as elements of fracture risk. This volumetric measure-
ment removes the confounding influences of bone size and
shape and provides an integral measure of cortical and trabec-
ular bone (40). In recent years, sophisticated imaging tech-
niques that combine non-invasive evaluation with high resolu-
tion [electron-beam computed tomography (EBCT), multi-de-
tector computed tomography (CT) and ultrafast spiral CT] now
detailed assessment of coronary artery disease and arterial
calcification in vivo (13). 
From the same CT axial scans used to obtain bone measure-
ments it is possible quantify the extent of calcification in the
aortic wall at the lowest thoracic vertebra (T12) and the first
four lumbar vertebrae (L1-L4), using specially designed soft-
ware (41). 
With these methods Schulz et al. investigated the relation be-
tween aortic calcification and the number of osteoporotic frac-
tures in 2348 healthy postmenopausal women (41). To deter-
mine whether increases in vascular calcification and bone loss
progress in parallel, baseline values were compared with mea-
surements obtained 9 months to 8 yr later in a subgroup of 228
women. Aortic calcifications were inversely related to bone
density and directly related to fractures. Compared with women
without calcification, the odds ratios for vertebral and hip frac-
tures in those with calcification were estimated to be 4.8 (95%
confidence interval, 3.6-6.5) and 2.9 (95% confidence interval,
1.8-4.8), respectively. The subgroup analysis of 228 women
longitudinally studied showed that the percentage of yearly in-
crease in aortic calcification accounted for 47% of the variance
in the percentage rate of bone loss. Moreover, a strong graded
association was observed between the progression of vascular
calcification and bone loss for each quartile. Women in the
highest quartile for gains in aortic calcification had four times
greater yearly bone loss (5.3 vs.1.3% yearly) than women of
similar age in the lowest quartile (41). Therefore in this study it
has been demonstrated that aortic calcifications are a strong
predictor for low bone density and fragility fractures (41). A
negative relationship between BMD and aortic calcification
both assessed by CT, has been recently confirmed in a biracial
cohort of 490 middle-aged women in the Study of Women’s
Health Across the Nation (SWAN study) (42).
Dual X-ray Absorptiometry (DXA) 
Dual energy X-ray absorptiometry (DXA) measurements of
spine and hip bone mineral density (BMD) have an important
role as a clinical tool for the evaluation of individuals at risk of
osteoporosis, and in helping clinicians give advice to patients
about the appropriate use of antifracture treatment. Compared
with alternative bone densitometry techniques such QCT and
QUS, DXA has a number of significant advantages that include
a consensus that BMD results can be interpreted using the
World Health Organization (WHO) T-score definition of osteo-
porosis, a proven ability to predict fracture risk, and proven ef-
fectiveness at targeting antifracture treatments (43). 
DXA at lumbar spine and femoral neck was utilized in order to
investigate the independent association between BMD and the
severity of atherosclerosis in a large population of post-
menopausal women (N=1456, age range 60-85) using aortic
calcification as a marker of cardiovascular disease, in an ob-
servational study published in 2003 (44). Aortic calcification
was graded on lateral radiographs according to Kauppila (30).
In this study the severity score of AAC showed statistically sig-
nificant negative correlation with BMD at hip, suggesting that
severe osteoporosis at hip may indicate advanced atheroscle-
rosis and thereby an increased risk for not only hip fractures
but also for coronary heart disease (44). In a prospective epi-
demiological study successively published from the same
group (45), a significant association at baseline between ad-
vanced AAC and lower BMD has been demonstrated; consid-
ering the annual rate of changes in AAC versus annual rate of
changes in hip BMD, women with the most progressive AAC
revealed the highest annual rate of bone loss at the hip (45). It
has been also demonstrated that the AAC severity was inde-
pendent predictor of hip fracture after adjustment for age (45,
46). 
The visual semiquantitative method for identification of verte-
bral fractures has been applied to images of the spine acquired
by fan-beam DXA devices, and called “instant vertebral as-
sessment” (IVA ) by Hologic and “vertebral fracture assess-
ment” (VFA) by GE/Lunar. The scanner arm of some models of
densitometers can be rotated 90°, so that lateral scans can be
obtained with the patient in the supine position without reposi-
tioning (Figure 1). The main attraction of IVA is that the effec-
tive dose-equivalent to the patient is considerably lower than
for conventional radiography (47). IVA has been compared with
SQ evaluation of spinal radiographs demonstrating good
agreement (96.3%, k=0.79) in classifying vertebrae as normal
or deformed in the 1978 of 2093 vertebrae deemed analyzable
on both the DXA scans and conventional radiographs (48).
IVA/VFA showed good sensitivity (91.9%) in the identification
of moderate/severe SQ deformities and an excellent negative
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predictive value (98%) to distinguish subjects with very low risk
of vertebral fractures from those with possible fractures. The
availability of a rapid, low-dose, method for assessment of ver-
tebral fractures, using advanced fan-beam DXA devices, pro-
vides a practical means for integrated assessment of BMD and
vertebral fracture status. This approach allows the identification
of most osteoporotic vertebral fractures, even asymptomatic, in
patients with low BMD improving selection of candidates for
therapeutic intervention.
A new method for the evaluation of aorta calcification by DXA
has been recently suggested: during an IVA scan sufficient soft
tissue anterior to the lumbar spine can be included to allow for
the detection of calcified plaques in the abdominal aorta (Fig-
ure 2). There is good agreement between IVA and lateral radi-
ographs for the detection of AAC (49), similar to the agreement
between the two modalities for vertebral fracture detection (48).
A quick and simple method was developed for the quantifica-
tion of AAC (49) and is called AAC-8. The AAC-8 scale esti-
mates the total length of calcification of the anterior and poste-
rior wall of the aorta, assigning a score between 0-4 (Table I).
The sum of the two scores for the anterior and posterior walls
gives the AAC-8 score; an AAC-8 score greater than two is
considered moderate to severe AAC on this scale (49). 
IVA’s new indication for the detection of AAC may have as
much clinical significance as its previous indication for the de-
tection of vertebral fractures.
It has been demonstrated that most patients at high risk for os-
teoporotic fracture are at high risk for cardiovascular disease
(11); therefore, a single IVA exam could assist in stratifying pa-
tients into high and low risk groups for two highly prevalent and
significant health care problems.
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